10-K: Healthcare AI Acquisition Corp. Files 10-K, Faces Nasdaq Delisting Amid Business Combination Efforts

Healthcare AI Acquisition Corp. files its annual report on Form 10-K, disclosing ongoing efforts to complete a business combination with Leading Group Limited while navigating a Nasdaq delisting notice.

Summary

• Healthcare AI Acquisition Corp. (HAIA) filed its annual report on Form 10-K for the fiscal year ended December 31, 2024.
• HAIA is a blank check company focused on effecting a business combination.
• The company received a delisting notice from Nasdaq due to non-compliance with IM-5101-2, as it did not complete a business combination within 36 months of its IPO registration statement's effectiveness.
• HAIA's securities have been trading on the OTC Markets Group since December 17, 2024.
• HAIA entered into a Business Combination Agreement with Leading Group Limited on August 15, 2024, but the transaction has not yet been completed.
• The company's financial statements have been prepared assuming that the company will continue as a going concern.
• The company had a working capital deficit of $1,277,029 as of December 31, 2024.
• The company had $4,664,536 in the trust account as of December 31, 2024.
• The company had net income of $56,844 for the year ended December 31, 2024.
• The company has identified a material weakness in its internal control over financial reporting.
• The company has until June 14, 2025, to complete a business combination.
• If the company does not complete a business combination, it will redeem its public shares and liquidate.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is actively pursuing a business combination, it faces significant challenges, including a delisting notice, a working capital deficit, and a material weakness in internal control. The company's ability to continue as a going concern is also in doubt.

Positives

• The company is actively pursuing a business combination with Leading Group Limited.
• The company has the option to extend the business combination deadline to June 14, 2025.
• The company has identified a material weakness in its internal control over financial reporting and is taking steps to remediate it.

Negatives

• The company received a delisting notice from Nasdaq and its securities are now trading on the OTC Markets Group.
• The company has a working capital deficit of $1,277,029 as of December 31, 2024.
• The company has identified a material weakness in its internal control over financial reporting.
• The company's independent registered public accounting firms report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern.

Risks

• Failure to complete the business combination with Leading Group Limited.
• Inability to obtain additional financing to complete the business combination or fund operations.
• Redemption of public shares could reduce the amount of cash available for the business combination.
• The company may be forced to liquidate if it cannot complete a business combination by June 14, 2025.
• The company may be deemed an investment company under the Investment Company Act.
• The company is dependent on its executive officers and directors, and their loss could adversely affect the company's ability to operate.
• The company may be a passive foreign investment company, or PFIC, which could result in adverse U.S. federal income tax consequences to U.S. investors.

Future Outlook

The company is focused on completing its business combination with Leading Group Limited and may seek additional financing to support the transaction.

Industry Context

The document reflects the challenges faced by SPACs in the current market, including regulatory scrutiny, competition for targets, and the need to complete business combinations within a specified timeframe. The delisting notice from Nasdaq highlights the pressure on SPACs to deliver results to investors.

Comparison to Industry Standards

• The challenges faced by Healthcare AI Acquisition Corp. are typical of many SPACs, including the need to complete a business combination within a specific timeframe and the risk of redemption by public shareholders.
• The company's efforts to extend the business combination deadline and secure additional financing are common strategies employed by SPACs facing similar challenges.
• The company's decision to trade on the OTC Markets Group after receiving a delisting notice from Nasdaq is a common alternative for companies seeking to maintain trading liquidity.

Management Changes

Related Party Transactions

• The company has engaged in several related party transactions, including loans from the sponsor and payments for administrative services.
• The company entered into a Warrant Exchange Agreement with Healthcare AI Acquisition LLC (the Former Sponsor) whereby at the time of the initial business combination, the Former Sponsor will surrender for cancelation 11,124,960 private placement warrants purchased at the time of the IPO in exchange for the Company issuing to the Former Sponsor 500,000 Class A Shares.

Stakeholder Impact

• Shareholders face the risk of dilution and potential loss of investment if the business combination is not successful.
• Warrant holders may see their warrants expire worthless if the business combination is not completed.
• The company's employees and service providers may be affected by the company's financial condition and ability to continue operations.

Next Steps

• Complete the business combination with Leading Group Limited.
• Obtain additional financing, if needed.
• Remediate the material weakness in internal control over financial reporting.
• Comply with the terms of the Business Combination Agreement.

Key Dates

Keywords

business combination, Leading Group, SPAC, delisting, warrants, redemption, trust account, financial reporting, internal control, AI, Healthcare, Acquisition